AxioMed Spine Corporation ( Axioms Com), a spinal orthopedic company focused on the development of products designed to restore spinal function in patients with degenerative spinal disease by advancing the standard of care beyond fusion and first generation total disk replacement, today announced the completion of a new funding round to raise $3. 6 million of current and new investors
AxioMed Spine Corporation
AxioMed’s mission is to develop spinal function-focused products for patients with degenerative spine disease, thereby advancing the standard of care beyond fusion and first generation total disk replacement. The company’s leading products, Freedom Lumbar and Cervical Disks, have been developed and designed by a team of clinicians and experts in the fields of biomechanics, pathology, spinal surgery and polymer science. Freedom Lumbar and Cervical Disks have been granted CE Mark approval for distribution in the European Union In addition, the Company is pursuing US regulatory approval for its Freedom Technology Focusing on restoring the natural function of the spine, AxioMed will enhance human health through research, innovation, development and service worldwide. For more information about AxioMed, please visit our website at
